Editor and Publisher ... Henry enters his twelve (12) year at RegMed Investors which aggregates, curates and creates bottom-line content of regenerative medicine and cell therapy news providing a "vetted" selection of relevant and high-impact synthesis. He was VP - Strategic Planning... More
Instablogged StocksStocks that instabloggers have most recently written about
- 1 Tomorrow's Jobs Number, Real Or Fake, Has Tr...
- 2 Benitec Q&A Meets ASX Rules
- 3 Top 20 Stem Cell Stocks For 2015.
- 4 IBM's New Growth Target
- 5 The Crude Oil Over-Supply Trade
- 1 Chris DeMuth Jr.
- 2 Axion Power Host
- 3 Dividend Growth Investor
- 4 Gregory Mannarino
- 5 Dividends4Life